Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing
-
Published:2024-04
Issue:4
Volume:9
Page:102385
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Takeshita T.ORCID,
Iwamoto T.ORCID,
Niikura N.,
Watanabe K.ORCID,
Kikawa Y.ORCID,
Kobayashi K.,
Iwakuma N.,
Okamura T.ORCID,
Tada H.ORCID,
Ozaki S.,
Okuno T.,
Toh U.,
Yamamoto Y.ORCID,
Tsuneizumi M.,
Ishiguro H.,
Masuda N.,
Saji S.ORCID
Funder
AstraZeneca
AstraZeneca KK
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献